Public Citizen Urges HHS To Use Patent Authorities To Produce GLP-1 Drugs For Public Programs

By Maaisha Osman / August 5, 2024 at 6:34 PM

Public Citizen is calling on HHS Secretary Xavier Becerra to reduce the cost of weight-loss drugs Ozempic and Wegovy by using a rarely invoked statute to compel brand manufacturers to license their patents to the government, which could then allow generic manufacturers to produce and supply these drugs to federal health programs.


Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.